Syntis Bio logo

Syntis Bio

Milton, MA

Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability.

syntis.bio

Company Details

Founded

2022

Employees

Between 5 - 20 employees

Raised

$53,372,180

Headquarters Location

Milton, MA

Public

No

Acquired

No

CEO

Rahul DhandaRahul Dhanda

Founders

Rahul Dhanda
Rahul Dhanda
Giovanni Traverso
Giovanni Traverso

Company Collections

These are collections Syntis Bio is a part of. Click on the collection name to view similar companies.

Syntis Bio's Industries

Syntis Bio Headquarters Location

50 Adams Street Suite 870073, Milton, MA 02187

Total Amount Raised: $53,372,180

Syntis Bio Funding Rounds

  • Series A

    $33,000,000

    Series A Investors

    Cerberus Capital Management
    Apollo Labs
    W.R. Berkley
    Touchdown Ventures
    Portal Innovations
    Woori Venture Partners
    Safar Partners
    Bold Capital Partners
    Colorcon Ventures
    Mansueto Investments

  • Grant

    $5,000,000

    Grant Investors

    National Institutes of Health (NIH)

  • Seed

    $15,372,179

    Seed Investors

    Portal Innovations
    Colorcon Ventures
    Touchdown Ventures
    Bold Capital Partners
    Safar Partners
Funding info provided by Diffbot.

Syntis Bio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Syntis Bio.

Recent reviews